Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
By G. Bougeard, M. Renaux-Petel, J. Flaman, C. Charbonnier, Pierre Fermey, M. Belotti, M. Gauthier-Villars, D. Stoppa-Lyonnet, É. Consolino, L. Brugières and 8 more. Journal of Clinical Oncology, 2015
669 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/db1551466a9a24295eca9abfc9c06ff29ef42bd7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
Citations in the corpus
- Variable population prevalence estimates of germline TP53 variants: a gnomAD-based analysis (2018, background): “The diagnosis of LFS is made based on clinical criteria that account for both personal and family history of cancer (Bougeard et al., 2015).”